Close Menu
Home » SpeeDx, QuantuMDx Collaborate with FIND on POC Molecular Diagnostics for STIs

SpeeDx, QuantuMDx Collaborate with FIND on POC Molecular Diagnostics for STIs

Nov 07, 2019
|
staff reporter

NEW YORK – SpeeDx and QuantuMDx on Thursday announced a collaboration with the Foundation for Innovative New Diagnostics (FIND) to assess the feasibility of porting SpeeDx sexually transmitted infection tests to the QuantuMDx point-of-care testing device.

FIND is funding the project with an undisclosed amount.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Lawsuit on Not Knowing Father's Test Result

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.

Lots and Lots of Triglycerides

LiveScience reports that a novel mutation in the LPL gene was uncovered in three siblings with very high triglyceride levels.

Image Errors Investigated

The president of Nankai University is embroiled in a data manipulation scandal, the South China Morning Post reports.

PNAS Studies on Supercentenarians, Blood Cell Differentiation in AML, Beetle Evolution

In PNAS this week: cytotoxic CD4 T cell signature in supercentenarians, evolutionary history of beetles, and more.

Dec
04
Featured Webinar

Integrating Genetic Data in Clinical Workflows: How CCPM Established a Personalized Health Framework

Sponsored by
BC Platforms

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).

What's Popular?

In Point-of-Care Testing

  1. Linear Diagnostics Lands £2M Investment

  2. Inflammatix Inks BARDA Contract for up to $72M

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.